<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="doi: 10.1016/j.jgar.2020.09.025 : Review A Possible Application of High Dose" exact="Vitamin C" post="in the Prevention and Therapy for Coronavirus Infections HoangBa"/>
 <result pre="Dose Vitamin C in the Prevention and Therapy for Coronavirus" exact="Infections" post="HoangBa X.aShawD. GraemebFangWilliamcHanBoaâ�Ž[a], [b], [c], â�ŽCorresponding author at: Departments"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="long as the COVID-19 resource centre remains active. Highlights â€¢Viral" exact="infections" post="such as SARS-CoV-2 (COVID-19), influenza, RSV, and many others"/>
 <result pre="vitamin C as therapeutic agent can favorably impact patient with" exact="viral pneumonia" post="and ARDS in severe SAR-CoV-2 infected patients by decreasing"/>
 <result pre="C as therapeutic agent can favorably impact patient with viral" exact="pneumonia" post="and ARDS in severe SAR-CoV-2 infected patients by decreasing"/>
 <result pre="redox balance and reduce the tissue damages in patients with" exact="viral pneumonia" post="and ARDS â€¢Further clinical trials are needed to validate"/>
 <result pre="balance and reduce the tissue damages in patients with viral" exact="pneumonia" post="and ARDS â€¢Further clinical trials are needed to validate"/>
 <result pre="therapeutic protocol for high dose of vitamin C treatment for" exact="pneumonia" post="and ARDS in patients with viral infection. Abstract Coronaviruses"/>
 <result pre="vitamin C treatment for pneumonia and ARDS in patients with" exact="viral infection." post="Abstract Coronaviruses such as SARS-CoV-2 and influenza viruses increase"/>
 <result pre="as a safe and effective therapy for severe cases of" exact="respiratory" post="viral infections. Morbidity, mortality, infectiveness, and spread of infectious"/>
 <result pre="a safe and effective therapy for severe cases of respiratory" exact="viral" post="infections. Morbidity, mortality, infectiveness, and spread of infectious diseases"/>
 <result pre="of respiratory viral infections. Morbidity, mortality, infectiveness, and spread of" exact="infectious diseases" post="are dependent on the host-pathogen relationship. Given the lack"/>
 <result pre="that may be immunosuppressive, adrenal depressive, and toxic, complicating the" exact="disease" post="course. In order to effectively fight the novel virus,"/>
 <result pre="therapeutic agents with proven antioxidant, anti-inflammatory and immune-supportive properties. Supplemental" exact="Vitamin C" post="may also provide additional benefits for the prevention of"/>
 <result pre="C may also provide additional benefits for the prevention of" exact="viral" post="infections, shorten the course, and lessen the complication of"/>
 <result pre="lessen the complication of the disease. Keywords coronavirus Oxidative stress" exact="Vitamin C" post="Ascorbic Acid Viral pneumonia 1 Introduction Most cases of"/>
 <result pre="the disease. Keywords coronavirus Oxidative stress Vitamin C Ascorbic Acid" exact="Viral" post="pneumonia 1 Introduction Most cases of human coronavirus infection"/>
 <result pre="disease. Keywords coronavirus Oxidative stress Vitamin C Ascorbic Acid Viral" exact="pneumonia" post="1 Introduction Most cases of human coronavirus infection are"/>
 <result pre="Acid Viral pneumonia 1 Introduction Most cases of human coronavirus" exact="infection" post="are mild, and patients usually can recover without complication"/>
 <result pre="or treatment. However, recent epidemics of the two coronaviruses, severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome"/>
 <result pre="treatment. However, recent epidemics of the two coronaviruses, severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus"/>
 <result pre="However, recent epidemics of the two coronaviruses, severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV),"/>
 <result pre="coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV), have affected more than 10,000 people"/>
 <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV), have affected more than 10,000 people with"/>
 <result pre="SARS-CoV [1] and 37% for MERS-CoV [2], [3]. A new" exact="respiratory" post="illness, SAR-CoV-2 (COVID-19), is genetically similar to SARS-CoV/MERS-CoV viruses"/>
 <result pre="under revision in June 2020, the WHO has reported a" exact="total" post="of 10.5+ million confirmed SARS-CoV-2 infected cases including 512kâ€‰+â€‰deaths"/>
 <result pre="including 512kâ€‰+â€‰deaths [4]. As the global case numbers of SAR-CoV-2" exact="infection" post="keep rising, health experts are focused on finding a"/>
 <result pre="of millions of people every year such as HIV and" exact="respiratory" post="syncytial virus (RSV) [5]. Therefore, we should rigorously explore"/>
 <result pre="report with 41 patients reported that all 41 patients exhibited" exact="pneumonia" post="and had complications, including acute respiratory distress syndrome (29%),"/>
 <result pre="that all 41 patients exhibited pneumonia and had complications, including" exact="acute" post="respiratory distress syndrome (29%), acute cardiac injury (12%), and"/>
 <result pre="all 41 patients exhibited pneumonia and had complications, including acute" exact="respiratory" post="distress syndrome (29%), acute cardiac injury (12%), and secondary"/>
 <result pre="patients exhibited pneumonia and had complications, including acute respiratory distress" exact="syndrome" post="(29%), acute cardiac injury (12%), and secondary infection (10%)."/>
 <result pre="pneumonia and had complications, including acute respiratory distress syndrome (29%)," exact="acute" post="cardiac injury (12%), and secondary infection (10%). 13 (32%)"/>
 <result pre="acute respiratory distress syndrome (29%), acute cardiac injury (12%), and" exact="secondary" post="infection (10%). 13 (32%) patients were admitted to the"/>
 <result pre="respiratory distress syndrome (29%), acute cardiac injury (12%), and secondary" exact="infection" post="(10%). 13 (32%) patients were admitted to the ICU"/>
 <result pre="of 99 confirmed cases, found that 17 (17%) patients developed" exact="acute" post="respiratory distress syndrome (ARDS) that led to 11 (11%)"/>
 <result pre="99 confirmed cases, found that 17 (17%) patients developed acute" exact="respiratory" post="distress syndrome (ARDS) that led to 11 (11%) patients"/>
 <result pre="cases, found that 17 (17%) patients developed acute respiratory distress" exact="syndrome" post="(ARDS) that led to 11 (11%) patients quickly worsening"/>
 <result pre="that led to 11 (11%) patients quickly worsening in a" exact="short" post="period and dying of multiple organ failure [9]. These"/>
 <result pre="anti-viral drugs. Corticosteroids are frequently used to treat patients with" exact="viral" post="illnesses by reducing inflammatory-induced organ damage. However, based on"/>
 <result pre="corticosteroids failed to achieve mortality rate reduction and potentially delayed" exact="viral" post="clearance [11], [12]. According to a large scale study"/>
 <result pre="China, high-dose corticosteroids were associated with increased mortality and longer" exact="viral" post="shedding in patients with influenza A (H7N9) viral pneumonia"/>
 <result pre="and longer viral shedding in patients with influenza A (H7N9)" exact="viral pneumonia" post="[13]. This fact was confirmed by a larger meta-analysis"/>
 <result pre="longer viral shedding in patients with influenza A (H7N9) viral" exact="pneumonia" post="[13]. This fact was confirmed by a larger meta-analysis"/>
 <result pre="confirmed by a larger meta-analysis of twenty-three studies with a" exact="total" post="patient population of nâ€‰=â€‰6,105 by Zhang et al. assessing"/>
 <result pre="doses of corticosteroids were observed to increase the risk of" exact="nosocomial infections" post="of acute lung injury/ARDS and severe pneumonia; patients were"/>
 <result pre="of corticosteroids were observed to increase the risk of nosocomial" exact="infections" post="of acute lung injury/ARDS and severe pneumonia; patients were"/>
 <result pre="were observed to increase the risk of nosocomial infections of" exact="acute" post="lung injury/ARDS and severe pneumonia; patients were associated with"/>
 <result pre="lung injury/ARDS and severe pneumonia; patients were associated with prolonged" exact="viral" post="shedding of hematopoietic cell transplant recipients infected with seasonal"/>
 <result pre="by severe influenza infections; however, they increase the risk of" exact="opportunistic infections" post="that occur secondary to immunosuppression. Administration of corticosteroids is"/>
 <result pre="severe influenza infections; however, they increase the risk of opportunistic" exact="infections" post="that occur secondary to immunosuppression. Administration of corticosteroids is"/>
 <result pre="however, they increase the risk of opportunistic infections that occur" exact="secondary" post="to immunosuppression. Administration of corticosteroids is likely to increase"/>
 <result pre="corticosteroids might be associated with a higher incidence of hospital-acquired" exact="pneumonia" post="and longer duration of mechanical ventilation and ICU stay."/>
 <result pre="offer clues for developing a more effective therapy. Viruses cause" exact="infections" post="that are often associated with redox modificationâ€™s characteristic of"/>
 <result pre="are one of the key events in the pathogenesis of" exact="respiratory" post="viral infection in all phases of the disease, contributing"/>
 <result pre="one of the key events in the pathogenesis of respiratory" exact="viral infection" post="in all phases of the disease, contributing to severe"/>
 <result pre="of the key events in the pathogenesis of respiratory viral" exact="infection" post="in all phases of the disease, contributing to severe"/>
 <result pre="activity of several signaling pathways. An oxidative imbalance caused by" exact="viral" post="infections [18], ligand/receptor binding [19], or cytokine storm [20]"/>
 <result pre="of several signaling pathways. An oxidative imbalance caused by viral" exact="infections" post="[18], ligand/receptor binding [19], or cytokine storm [20] could"/>
 <result pre="ligand/receptor binding [19], or cytokine storm [20] could result in" exact="localized" post="oxidation of reactive residues of redox-sensitive proteins. Increased oxidative"/>
 <result pre="result in localized oxidation of reactive residues of redox-sensitive proteins." exact="Increased" post="oxidative stress leads to a systematic inflammatory response from"/>
 <result pre="to ARDS, the key pathology in the high mortality of" exact="acute" post="respiratory viral infections [21]. Despite the anti-viral role of"/>
 <result pre="ARDS, the key pathology in the high mortality of acute" exact="respiratory" post="viral infections [21]. Despite the anti-viral role of cytokines"/>
 <result pre="the key pathology in the high mortality of acute respiratory" exact="viral" post="infections [21]. Despite the anti-viral role of cytokines in"/>
 <result pre="key pathology in the high mortality of acute respiratory viral" exact="infections" post="[21]. Despite the anti-viral role of cytokines in respiratory"/>
 <result pre="viral infections [21]. Despite the anti-viral role of cytokines in" exact="respiratory" post="infections, their overproduction during the cytokine storm is more"/>
 <result pre="a common immunological defense mechanism, immune cells respond to foreign" exact="infection" post="by producing large quantities of reactive oxygen species (ROS)"/>
 <result pre="[24]. 5 A possible role of vitamin C in anti-viral" exact="infection" post="and related complications Vitamin C has many properties that"/>
 <result pre="role of vitamin C in anti-viral infection and related complications" exact="Vitamin C" post="has many properties that make it a valuable therapeutic"/>
 <result pre="many properties that make it a valuable therapeutic agent for" exact="respiratory" post="infections. It is a potent antioxidant with anti-inflammatory and"/>
 <result pre="It is a potent antioxidant with anti-inflammatory and immune-supportive properties." exact="Vitamin C" post="is a small water-soluble molecule that readily acts as"/>
 <result pre="vitamin C in their livers with increased production during stress." exact="Vitamin C" post="is an essential vitamin that acts as a cofactor"/>
 <result pre="these molecules are central to cellular function and homeostasis. Additionally," exact="Vitamin C" post="plays a significant role in viral infection, including attenuation"/>
 <result pre="and homeostasis. Additionally, Vitamin C plays a significant role in" exact="viral infection," post="including attenuation of the proinflammatory response, enhancement of epithelial"/>
 <result pre="viral infection, including attenuation of the proinflammatory response, enhancement of" exact="epithelial" post="barrier function, increasing alveolar fluid clearance, and prevention of"/>
 <result pre="vitamin C is an essential factor in the production of" exact="type I" post="interferons during the anti-viral immune response [28]. Vitamin C"/>
 <result pre="of type I interferons during the anti-viral immune response [28]." exact="Vitamin C" post="has also been shown to up-regulates Natural killer (NK)"/>
 <result pre="can be used as an inactivating agent for the fixed" exact="rabies" post="virus [30]. Other studies have used this vitamin as"/>
 <result pre="an inactivating agent for both RNA and DNA viruses, lessening" exact="viral" post="infectivity. In addition, vitamin C can detoxify viral products"/>
 <result pre="viruses, lessening viral infectivity. In addition, vitamin C can detoxify" exact="viral" post="products that produce pain and inflammation. [29], [31]. Evidence"/>
 <result pre="inflammation. [29], [31]. Evidence has shown its effectiveness in treating" exact="pneumonia" post="and infection due to its direct inhibitory effects on"/>
 <result pre="[31]. Evidence has shown its effectiveness in treating pneumonia and" exact="infection" post="due to its direct inhibitory effects on pathogens [32]."/>
 <result pre="due to its direct inhibitory effects on pathogens [32]. Also," exact="Vitamin C" post="is present in the epithelial lining of the respiratory"/>
 <result pre="on pathogens [32]. Also, Vitamin C is present in the" exact="epithelial" post="lining of the respiratory tract where it functions as"/>
 <result pre="Vitamin C is present in the epithelial lining of the" exact="respiratory" post="tract where it functions as a local mucosal protecting"/>
 <result pre="as a local mucosal protecting agent, helping ameliorate symptoms of" exact="upper" post="respiratory tract infections [33]. Sepsis is a life-threatening illness"/>
 <result pre="a local mucosal protecting agent, helping ameliorate symptoms of upper" exact="respiratory" post="tract infections [33]. Sepsis is a life-threatening illness from"/>
 <result pre="mucosal protecting agent, helping ameliorate symptoms of upper respiratory tract" exact="infections" post="[33]. Sepsis is a life-threatening illness from a dysregulated"/>
 <result pre="of different treatments and supportive care for critically ill patients." exact="Fisher" post="B.J et al demonstrated in a mice model that"/>
 <result pre="Fisher B.J et al demonstrated in a mice model that" exact="Vitamin C" post="plays a crucial role in multiple pathways associated with"/>
 <result pre="C) in patients with hypovitaminosis C, during severe sepsis or" exact="septic shock," post="supports the endogenous synthesis of vasoactive compounds, reducing the"/>
 <result pre="the endogenous synthesis of vasoactive compounds, reducing the need for" exact="external" post="vasopressors. These vasopressors help with the widespread vasodilation during"/>
 <result pre="oxidative stress and inflammation during coronavirus infections, but also suppresses" exact="viral" post="replication and improves anti-viral immune defense and adrenal function."/>
 <result pre="replication and improves anti-viral immune defense and adrenal function. 6" exact="Vitamin C" post="in human clinical applications in anti-viral, pneumonia and sepsis"/>
 <result pre="function. 6 Vitamin C in human clinical applications in anti-viral," exact="pneumonia" post="and sepsis In a study looking at the impact"/>
 <result pre="of vitamin C on oxidative stress and inflammation in common" exact="infectious disease," post="community-acquired pneumonia (CAP), researchers measured values including, reactive oxygen"/>
 <result pre="on oxidative stress and inflammation in common infectious disease, community-acquired" exact="pneumonia" post="(CAP), researchers measured values including, reactive oxygen species (ROS),"/>
 <result pre="reactive oxygen species (ROS), DNA damage, superoxide dismutase (SOD) activity," exact="tumor" post="necrosis factor-alpha (TNF-Î±), and IL-6 in patients. The results"/>
 <result pre="damage, TNF-Î±, and IL-6 but significantly decreased SOD.[37] Administration of" exact="Vitamin C" post="improved these redox imbalances by mitigating oxidative stress and"/>
 <result pre="trials have reported positive results in vitamin C therapy for" exact="respiratory" post="infections. Nathens et al. infused ascorbic acid at 1â€‰g"/>
 <result pre="in 594 surgically critically ill patients and found a significantly" exact="lower" post="incidence of acute lung injury and multiple organ failure"/>
 <result pre="critically ill patients and found a significantly lower incidence of" exact="acute" post="lung injury and multiple organ failure than in patients"/>
 <result pre="multiple organ failure than in patients receiving mechanical ventilation. [43]" exact="Vitamin C" post="also significantly improved the â€œtotal respiratory scoreâ€� in the"/>
 <result pre="mechanical ventilation. [43] Vitamin C also significantly improved the â€œtotal" exact="respiratory" post="scoreâ€� in the most severely ill patients with a"/>
 <result pre="respiratory scoreâ€� in the most severely ill patients with a" exact="respiratory" post="infection [44]. Fowler III AA et al. reported in"/>
 <result pre="scoreâ€� in the most severely ill patients with a respiratory" exact="infection" post="[44]. Fowler III AA et al. reported in a"/>
 <result pre="et al. reported in a case study of a 20-year-old" exact="female" post="who contracted respiratory enterovirus/rhinovirus infection that led to acute"/>
 <result pre="in a case study of a 20-year-old female who contracted" exact="respiratory" post="enterovirus/rhinovirus infection that led to acute lung injury and"/>
 <result pre="case study of a 20-year-old female who contracted respiratory enterovirus/rhinovirus" exact="infection" post="that led to acute lung injury and ARDS. Twelve"/>
 <result pre="20-year-old female who contracted respiratory enterovirus/rhinovirus infection that led to" exact="acute" post="lung injury and ARDS. Twelve hours following ECMO (extracorporeal"/>
 <result pre="[21]. Dietary antioxidants rich in vitamin C significantly attenuate hyperoxia-induced" exact="acute" post="inflammatory lung injury by enhancing macrophage function via reducing"/>
 <result pre="in patients who supplemented with antioxidant vitamin C and E.[46]" exact="Vitamin C" post="has also been shown to be effective against other"/>
 <result pre="in the low dose of 50â€‰mg/1â€‰kg body weight daily and" exact="short" post="time frame of only 96â€‰hours vitamin C infusion in"/>
 <result pre="vitamin C infusion in these patients with sepsis and ARDS." exact="Vitamin C" post="has been widely utilized in the prevention or treatment"/>
 <result pre="therapeutic dose of vitamin C (3.0â€‰g/day to 4.0â€‰g/day) during the" exact="disease" post="to better recover health. [51] Meta-analyses of randomized controlled"/>
 <result pre="studies have shown that vitamin C may protect against contrast-induced" exact="acute" post="kidney injury and shorten the duration of hospital and"/>
 <result pre="have shown that vitamin C may protect against contrast-induced acute" exact="kidney injury" post="and shorten the duration of hospital and ICU stay"/>
 <result pre="patients [52]. Hemila et al. identified 15 trials about preventing" exact="atrial fibrillation" post="in high-risk patients and found that vitamin C affects"/>
 <result pre="[52]. Hemila et al. identified 15 trials about preventing atrial" exact="fibrillation" post="in high-risk patients and found that vitamin C affects"/>
 <result pre="a high dose of IV vitamin C is effective against" exact="viral" post="infections such as the common cold, rhinovirus, avian virus"/>
 <result pre="high dose of IV vitamin C is effective against viral" exact="infections" post="such as the common cold, rhinovirus, avian virus H1N1,"/>
 <result pre="influenza [31], [54], [55]. 7 Optimal dose and administration of" exact="Vitamin C" post="for treatment of pneumonia and ARDS The dose and"/>
 <result pre="Optimal dose and administration of Vitamin C for treatment of" exact="pneumonia" post="and ARDS The dose and pharmacokinetics of vitamin C"/>
 <result pre="to be safe and demonstrated efficacy in preventing and ameliorate" exact="respiratory" post="and systemic infections [40]. The antioxidant capacity of vitamin"/>
 <result pre="safe and demonstrated efficacy in preventing and ameliorate respiratory and" exact="systemic" post="infections [40]. The antioxidant capacity of vitamin C is"/>
 <result pre="and demonstrated efficacy in preventing and ameliorate respiratory and systemic" exact="infections" post="[40]. The antioxidant capacity of vitamin C is dose-dependent,"/>
 <result pre="for the treatment of patients with severe illnesses such as" exact="viral pneumonia," post="ARDS, and sepsis. The treatment with a high dose"/>
 <result pre="preventive agent should be started at 2000â€‰mg and above. 8" exact="Vitamin C" post="safety and possible side effects Vitamin C has been"/>
 <result pre="and above. 8 Vitamin C safety and possible side effects" exact="Vitamin C" post="has been used for many decades, with few significant"/>
 <result pre="vitamin C is necessary to prevent scurvy, but the â€˜tolerable" exact="upper" post="intake level, as recommended by US nutritional recommendations, is"/>
 <result pre="cytotoxic chemotherapy in patients states that a high dose of" exact="Vitamin C" post="(1.5â€‰g/d body weight per 24â€‰hours) is safe and without"/>
 <result pre="study a dose curve from 30 to 110â€‰g/m2 of IV" exact="Vitamin C" post="and showed it safe and tolerable to patients even"/>
 <result pre="there is no concern for up to 2000â€‰mg daily. [60]." exact="Pneumonia" post="patients have been observed taking as much as 100â€‰g/day"/>
 <result pre="taking as much as 100â€‰g/day of vitamin C without developing" exact="diarrhea" post="and reported adverse side effects. A possible mechanism has"/>
 <result pre="the changes in vitamin C metabolism caused by a severe" exact="infection" post="[68]. Other possible side effects that have been reported"/>
 <result pre="the use of IV vitamin C in patients with end-stage" exact="renal failure" post="predisposed to oxaluria. It has been reported that vitamin"/>
 <result pre="reported that vitamin C intake as a possible cause of" exact="renal failure" post="and kidney stones through the metabolic conversion of ascorbate"/>
 <result pre="C intake as a possible cause of renal failure and" exact="kidney stones" post="through the metabolic conversion of ascorbate to oxalate hyperoxaluria"/>
 <result pre="intake as a possible cause of renal failure and kidney" exact="stones" post="through the metabolic conversion of ascorbate to oxalate hyperoxaluria"/>
 <result pre="function even improved [72], [73]. Case reports have described oxalate" exact="nephropathy" post="in burn patients after vitamin C administration (101â€‰g and"/>
 <result pre="than used in most clinical applications [74]. Glucose-6-phosphate dehydrogenase (G6PD)" exact="deficiency" post="is typically screened for prior to high dose IV"/>
 <result pre="dose IV C administration due to two case reports of" exact="hemolytic anemia" post="in G6PD deficient individuals following 80â€‰g intravenous administration.[75] However,"/>
 <result pre="IV C administration due to two case reports of hemolytic" exact="anemia" post="in G6PD deficient individuals following 80â€‰g intravenous administration.[75] However,"/>
 <result pre="in G6PD deficient individuals following 80â€‰g intravenous administration.[75] However, the" exact="lower" post="of intravenous vitamin C doses typically used for prevention"/>
 <result pre="therapy with less than 16â€‰g/day would be unlikely to cause" exact="hemolytic anemia" post="in G6PD deficient individuals due to lack of hydrogen"/>
 <result pre="with less than 16â€‰g/day would be unlikely to cause hemolytic" exact="anemia" post="in G6PD deficient individuals due to lack of hydrogen"/>
 <result pre="point-of-care glucometers, leading to false results.[76] This can lead to" exact="hypoglycemia" post="if aggressive insulin therapy is applied. Therefore, glucose measurements"/>
 <result pre="Trials Several ongoing clinical trials are investigating the effects of" exact="Vitamin C," post="or ascorbic acid, in patients with COVID-19. According to"/>
 <result pre="According to the clinical trials database (www.clinical-trials.gov), there are a" exact="total" post="of 9 active studies that are recruiting patients that"/>
 <result pre="9 active studies that are recruiting patients that have listed" exact="Vitamin C" post="or Ascorbic acid as one of the interventions. Three"/>
 <result pre="of these studies are specifically studying the interaction of infusing" exact="Vitamin C" post="through IV and its effects on COVID-19. One of"/>
 <result pre="of these studies (Identifier: NCT04323514), conducted in Italy, is an" exact="uncontrolled" post="longitudinal study in a cohort of 200 hospitalized patients"/>
 <result pre="(Identifier: NCT04357782), is also studying the effects of administering intravenous" exact="Vitamin C" post="for coronavirus infection and on decreased oxygenation. They have"/>
 <result pre="studying the effects of administering intravenous Vitamin C for coronavirus" exact="infection" post="and on decreased oxygenation. They have a study cohort"/>
 <result pre="to test against the experimental arm of Hydroxychloroquine. 10 Conclusion" exact="Viral" post="infections such as SAR-CoV-2 (COVID-19), influenza, RSV, and many"/>
 <result pre="test against the experimental arm of Hydroxychloroquine. 10 Conclusion Viral" exact="infections" post="such as SAR-CoV-2 (COVID-19), influenza, RSV, and many others"/>
 <result pre="to oxidative cellular and tissue damage resulting in multi-organ failure." exact="Vitamin C" post="has demonstrated favorable therapeutic properties safety profiles throughout a"/>
 <result pre="C as a therapeutic agent can favorably impact patients with" exact="viral pneumonia" post="and ARDS in severe SAR-CoV-2 infected patients by decreasing"/>
 <result pre="as a therapeutic agent can favorably impact patients with viral" exact="pneumonia" post="and ARDS in severe SAR-CoV-2 infected patients by decreasing"/>
 <result pre="treatment with high doses for corticosteroids, antibacterial, and anti-viral drugs." exact="Vitamin C" post="also can be effective for primary prevention of viral"/>
 <result pre="and anti-viral drugs. Vitamin C also can be effective for" exact="primary" post="prevention of viral infections by boosting the innate immune"/>
 <result pre="Vitamin C also can be effective for primary prevention of" exact="viral" post="infections by boosting the innate immune defense. In infected"/>
 <result pre="C also can be effective for primary prevention of viral" exact="infections" post="by boosting the innate immune defense. In infected patients,"/>
 <result pre="may shorten the course and prevent the complication of the" exact="disease" post="[47][78]. In addition to vitamin C, other nutraceutical antioxidants"/>
 <result pre="improve redox balance and reduce tissue damages in patients with" exact="viral pneumonia" post="and ARDS. These possible agents included but are not"/>
 <result pre="redox balance and reduce tissue damages in patients with viral" exact="pneumonia" post="and ARDS. These possible agents included but are not"/>
 <result pre="pneumonia and ARDS. These possible agents included but are not" exact="limited" post="to tocopherol, lipoic acid, N-acetylcysteine, glutathione, L-carnitine, Coenzyme-Q10, zinc,"/>
 <result pre="control clinical trials, we recommend conducting comprehensive retrospective studies comparing" exact="disease" post="progression and post-infection complications among patients who were or"/>
 <result pre="COVID-19 pandemic. References References 1KsiazekT.G.ErdmanD.GoldsmithC.S.A novel coronavirus associated with severe" exact="acute" post="respiratory syndromeNew England journal of medicine3482020031953196612690092 2KuikenT.FouchierR.A.SchuttenM.Newly discovered coronavirus"/>
 <result pre="pandemic. References References 1KsiazekT.G.ErdmanD.GoldsmithC.S.A novel coronavirus associated with severe acute" exact="respiratory" post="syndromeNew England journal of medicine3482020031953196612690092 2KuikenT.FouchierR.A.SchuttenM.Newly discovered coronavirus as"/>
 <result pre="syndromeNew England journal of medicine3482020031953196612690092 2KuikenT.FouchierR.A.SchuttenM.Newly discovered coronavirus as the" exact="primary" post="cause of severe acute respiratory syndromeThe Lancet.36293802003263270 3de GrootR.J.BakerS.C.BaricR.S.Commentary:"/>
 <result pre="medicine3482020031953196612690092 2KuikenT.FouchierR.A.SchuttenM.Newly discovered coronavirus as the primary cause of severe" exact="acute" post="respiratory syndromeThe Lancet.36293802003263270 3de GrootR.J.BakerS.C.BaricR.S.Commentary: Middle East respiratory syndrome"/>
 <result pre="2KuikenT.FouchierR.A.SchuttenM.Newly discovered coronavirus as the primary cause of severe acute" exact="respiratory" post="syndromeThe Lancet.36293802003263270 3de GrootR.J.BakerS.C.BaricR.S.Commentary: Middle East respiratory syndrome coronavirus"/>
 <result pre="of severe acute respiratory syndromeThe Lancet.36293802003263270 3de GrootR.J.BakerS.C.BaricR.S.Commentary: Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study GroupJournal"/>
 <result pre="severe acute respiratory syndromeThe Lancet.36293802003263270 3de GrootR.J.BakerS.C.BaricR.S.Commentary: Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): announcement of the Coronavirus Study GroupJournal of"/>
 <result pre="7YangX.YuY.XuJ.Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet"/>
 <result pre="pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet" exact="Respiratory" post="Medicine.2020 8WangD.HuB.HuC.Clinical characteristics of 138 hospitalized patients with 2019"/>
 <result pre="8WangD.HuB.HuC.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusâ€&quot;infected" exact="pneumonia" post="in Wuhan, ChinaJama.2020 9ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyThe Lancet.2020 10LiG.De ClercqE.Therapeutic"/>
 <result pre="medicine392006 12ArabiY.M.MandourahY.Al-HameedF.Corticosteroid therapy for critically ill patients with Middle East" exact="respiratory" post="syndromeAmerican journal of respiratory and critical care medicine1976201875776729161116 13CaoB.GaoH.ZhouB.Adjuvant"/>
 <result pre="critically ill patients with Middle East respiratory syndromeAmerican journal of" exact="respiratory" post="and critical care medicine1976201875776729161116 13CaoB.GaoH.ZhouB.Adjuvant Corticosteroid Treatment in Adults"/>
 <result pre="medicine1976201875776729161116 13CaoB.GaoH.ZhouB.Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9)" exact="Viral" post="PneumoniaCrit Care Med.4462016e31832826934144 14ZhangY.SunW.SvendsenE.R.Do corticosteroids reduce the mortality of"/>
 <result pre="influenza A (H1N1) infection? A meta-analysisCritical Care.19120154625888424 15LamontagneF.BrielM.GuyattG.H.CookD.J.BhatnagarN.MeadeM.Corticosteroid therapy for" exact="acute" post="lung injury, acute respiratory distress syndrome, and severe pneumonia:"/>
 <result pre="infection? A meta-analysisCritical Care.19120154625888424 15LamontagneF.BrielM.GuyattG.H.CookD.J.BhatnagarN.MeadeM.Corticosteroid therapy for acute lung injury," exact="acute" post="respiratory distress syndrome, and severe pneumonia: a meta-analysis of"/>
 <result pre="A meta-analysisCritical Care.19120154625888424 15LamontagneF.BrielM.GuyattG.H.CookD.J.BhatnagarN.MeadeM.Corticosteroid therapy for acute lung injury, acute" exact="respiratory" post="distress syndrome, and severe pneumonia: a meta-analysis of randomized"/>
 <result pre="in hematopoietic cell transplant patients infected with influenza virusBiology of" exact="Blood" post="and Marrow Transplantation.177201197998620870025 17DuaK.MalylaV.SinghviG.Increasing complexity and interactions of oxidative"/>
 <result pre="Marrow Transplantation.177201197998620870025 17DuaK.MalylaV.SinghviG.Increasing complexity and interactions of oxidative stress in" exact="chronic" post="respiratory diseases: An emerging need for novel drug delivery"/>
 <result pre="Transplantation.177201197998620870025 17DuaK.MalylaV.SinghviG.Increasing complexity and interactions of oxidative stress in chronic" exact="respiratory" post="diseases: An emerging need for novel drug delivery systemsChemico-biological"/>
 <result pre="immunology1511997351369 21FowlerIIIAAKimC.LeplerL.Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced" exact="acute" post="respiratory distress syndromeWorld journal of critical care medicine6120178528224112 22Al"/>
 <result pre="21FowlerIIIAAKimC.LeplerL.Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced acute" exact="respiratory" post="distress syndromeWorld journal of critical care medicine6120178528224112 22Al GhoulehI.KhooN.K.KnausU.G.Oxidases"/>
 <result pre="journal of critical care medicine6120178528224112 22Al GhoulehI.KhooN.K.KnausU.G.Oxidases and peroxidases in" exact="cardiovascular" post="and lung disease: new concepts in reactive oxygen species"/>
 <result pre="za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of" exact="tuberculosis" post="and respiratory diseases432020E00532026671 25VeraJ.C.RivasC.I.VelÃ¡squezF.V.ZhangR.H.ConchaI.I.GoldeD.W.Resolution of the facilitated transport of"/>
 <result pre="Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and" exact="respiratory" post="diseases432020E00532026671 25VeraJ.C.RivasC.I.VelÃ¡squezF.V.ZhangR.H.ConchaI.I.GoldeD.W.Resolution of the facilitated transport of dehydroascorbic acid"/>
 <result pre="immune functionNutrients.91120171211 27BhararaA.GrossmanC.GrinnanD.Intravenous vitamin C administered as adjunctive therapy for" exact="recurrent" post="acute respiratory distress syndromeCase reports in critical care20162016 28KimY.KimH.BaeS.Vitamin"/>
 <result pre="functionNutrients.91120171211 27BhararaA.GrossmanC.GrinnanD.Intravenous vitamin C administered as adjunctive therapy for recurrent" exact="acute" post="respiratory distress syndromeCase reports in critical care20162016 28KimY.KimH.BaeS.Vitamin C"/>
 <result pre="27BhararaA.GrossmanC.GrinnanD.Intravenous vitamin C administered as adjunctive therapy for recurrent acute" exact="respiratory" post="distress syndromeCase reports in critical care20162016 28KimY.KimH.BaeS.Vitamin C is"/>
 <result pre="activities of ascorbic acidSubcellular biochemistry1996Springer215231 30MadhusudanaS.N.ShamsundarR.SeetharamanS.In vitro inactivation of the" exact="rabies" post="virus by ascorbic acidInternational journal of infectious diseases812004212514690777 31ZarubaevV.SlitaA.LavrentyevaI.SmirnovVProtective"/>
 <result pre="inactivation of the rabies virus by ascorbic acidInternational journal of" exact="infectious" post="diseases812004212514690777 31ZarubaevV.SlitaA.LavrentyevaI.SmirnovVProtective Activity Of Ascorbic Acid At Influenza InfectionInfektsiya"/>
 <result pre="in immune function and infectionsVitam Miner.616720172376-1318.1000167 34FisherB.J.SeropianI.M.KraskauskasD.ThakkarJ.N.VoelkelN.F.NatarajanR.Ascorbic acid attenuates lipopolysaccharide-induced" exact="acute" post="lung injuryCritical care medicine39620111454146021358394 35FisherB.J.KraskauskasD.MartinE.J.Mechanisms of attenuation of abdominal"/>
 <result pre="injuryCritical care medicine39620111454146021358394 35FisherB.J.KraskauskasD.MartinE.J.Mechanisms of attenuation of abdominal sepsis induced" exact="acute" post="lung injury by ascorbic acidAmerican Journal of Physiology-Lung Cellular"/>
 <result pre="and septic shock?Critical Care.191201541826612352 37ChenY.LuoG.YuanJ.Vitamin C mitigates oxidative stress and" exact="tumor" post="necrosis factor-alpha in severe community-acquired pneumonia and LPS-induced macrophagesMediators"/>
 <result pre="mitigates oxidative stress and tumor necrosis factor-alpha in severe community-acquired" exact="pneumonia" post="and LPS-induced macrophagesMediators of inflammation20142014 38HosakoteY.M.JantziP.D.EshamD.L.Viral-mediated inhibition of antioxidant"/>
 <result pre="inhibition of antioxidant enzymes contributes to the pathogenesis of severe" exact="respiratory" post="syncytial virus bronchiolitisAmerican journal of respiratory and critical care"/>
 <result pre="the pathogenesis of severe respiratory syncytial virus bronchiolitisAmerican journal of" exact="respiratory" post="and critical care medicine1831120111550156021471094 39AndradesM.RitterC.de OliveiraM.R.StreckE.L.MoreiraJ.C.F.Dal-PizzolF.Antioxidant treatment reverses organ"/>
 <result pre="oxidative stressJournal of surgical research.16722011e307e31319959187 40CarrA.C.RosengraveP.C.BayerS.ChambersS.MehrtensJ.ShawG.M.Hypovitaminosis C and vitamin C" exact="deficiency" post="in critically ill patients despite recommended enteral and parenteral"/>
 <result pre="patientsAnnals of surgery.2366200281412454520 44HemilÃ¤H.Vitamin C and community-acquired pneumoniaAmerican journal of" exact="respiratory" post="and critical care medicine1845201162162221885641 45PatelV.DialK.WuJ.Dietary Antioxidants Significantly Attenuate Hyperoxia-Induced"/>
 <result pre="respiratory and critical care medicine1845201162162221885641 45PatelV.DialK.WuJ.Dietary Antioxidants Significantly Attenuate Hyperoxia-Induced" exact="Acute" post="Inflammatory Lung Injury by Enhancing Macrophage Function via Reducing"/>
 <result pre="and critical care medicine1845201162162221885641 45PatelV.DialK.WuJ.Dietary Antioxidants Significantly Attenuate Hyperoxia-Induced Acute" exact="Inflammatory" post="Lung Injury by Enhancing Macrophage Function via Reducing the"/>
 <result pre="C infusion on organ failure and biomarkers of inflammation and" exact="vascular" post="injury in patients with sepsis and severe acute respiratory"/>
 <result pre="inflammation and vascular injury in patients with sepsis and severe" exact="acute" post="respiratory failure: the CITRIS-ALI randomized clinical trialJama.3221320191261127031573637 50HemilÃ¤H.ChalkerE.Vitamin C"/>
 <result pre="and vascular injury in patients with sepsis and severe acute" exact="respiratory" post="failure: the CITRIS-ALI randomized clinical trialJama.3221320191261127031573637 50HemilÃ¤H.ChalkerE.Vitamin C for"/>
 <result pre="controlled trialsBioMed research international20182018 52SadatU.UsmanA.GillardJ.H.BoyleJ.R.Does ascorbic acid protect against contrast-induced" exact="acute" post="kidney injury in patients undergoing coronary angiography: a systematic"/>
 <result pre="trialsBioMed research international20182018 52SadatU.UsmanA.GillardJ.H.BoyleJ.R.Does ascorbic acid protect against contrast-induced acute" exact="kidney injury" post="in patients undergoing coronary angiography: a systematic review with"/>
 <result pre="systematic review with meta-analysis of randomized, controlled trialsJournal of the" exact="American" post="College of Cardiology.622320132167217523994417 53HemilÃ¤H.SuonsyrjÃ¤T.Vitamin C for preventing atrial fibrillation"/>
 <result pre="of the American College of Cardiology.622320132167217523994417 53HemilÃ¤H.SuonsyrjÃ¤T.Vitamin C for preventing" exact="atrial fibrillation" post="in high risk patients: a systematic review and meta-analysisBMC"/>
 <result pre="the American College of Cardiology.622320132167217523994417 53HemilÃ¤H.SuonsyrjÃ¤T.Vitamin C for preventing atrial" exact="fibrillation" post="in high risk patients: a systematic review and meta-analysisBMC"/>
 <result pre="fibrillation in high risk patients: a systematic review and meta-analysisBMC" exact="cardiovascular" post="disorders17120174928143406 54Marcial-VegaV.GG-TIdxianLevyT.E.Intravenous ascorbic acid and hydrogen peroxide in the"/>
 <result pre="recommendations for vitamin C intakeJama.2811519991415142310217058 61PadayattyS.J.RiordanH.D.HewittS.M.KatzA.HofferL.J.LevineM.Intravenously administered vitamin C as" exact="cancer" post="therapy: three casesCmaj.1747200693794216567755 62ChenQ.EspeyM.G.SunA.Y.Ascorbate in pharmacologic concentrations selectively generates"/>
 <result pre="with advanced cancerCancer chemotherapy and pharmacology.721201313914623670640 68CathcartRFVitamin C, titrating to" exact="bowel" post="tolerance, anascorbemia, and acute induced scurvyMedical Hypotheses.7111981135913767321921 69WelshJ.WagnerB.Vanâ€™t ErveT.Pharmacological"/>
 <result pre="and pharmacology.721201313914623670640 68CathcartRFVitamin C, titrating to bowel tolerance, anascorbemia, and" exact="acute" post="induced scurvyMedical Hypotheses.7111981135913767321921 69WelshJ.WagnerB.Vanâ€™t ErveT.Pharmacological ascorbate with gemcitabine for"/>
 <result pre="Hypotheses.7111981135913767321921 69WelshJ.WagnerB.Vanâ€™t ErveT.Pharmacological ascorbate with gemcitabine for the control of" exact="metastatic" post="and node-positive pancreatic cancer (PACMAN): results from a phase"/>
 <result pre="ascorbate with gemcitabine for the control of metastatic and node-positive" exact="pancreatic cancer" post="(PACMAN): results from a phase I clinical trialCancer chemotherapy"/>
 <result pre="with gemcitabine for the control of metastatic and node-positive pancreatic" exact="cancer" post="(PACMAN): results from a phase I clinical trialCancer chemotherapy"/>
 <result pre="serum ascorbic acid to serum vitamin B12, serum ferritin, and" exact="kidney stones" post="in US adultsArchives of internal medicine.1596199961962410090119 72GersterH.No contribution of"/>
 <result pre="ascorbic acid to serum vitamin B12, serum ferritin, and kidney" exact="stones" post="in US adultsArchives of internal medicine.1596199961962410090119 72GersterH.No contribution of"/>
 <result pre="intake of vitamins C and B6, and the risk of" exact="kidney stones" post="in menThe Journal of urology15561996184718518618271 74BuehnerM.PamplinJ.StuderL.Oxalate nephropathy after continuous"/>
 <result pre="of vitamins C and B6, and the risk of kidney" exact="stones" post="in menThe Journal of urology15561996184718518618271 74BuehnerM.PamplinJ.StuderL.Oxalate nephropathy after continuous"/>
 <result pre="risk of kidney stones in menThe Journal of urology15561996184718518618271 74BuehnerM.PamplinJ.StuderL.Oxalate" exact="nephropathy" post="after continuous infusion of high-dose vitamin C as an"/>
</results>
